Link Immunotherapeutics, Inc. — Form D
Link Immunotherapeutics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2021-04-12. The offering totals $17.3M, of which $14.3M was reported sold. Industry: Other.
Offering
- Filed: 2021-04-12
- Form: D
- Accession: 0001854151-21-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $17.3M
- Amount sold: $14.3M
- Remaining: $3.0M
- Investors: 9
- Date of first sale: 2021-03-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-395334
Issuer
- Name: Link Immunotherapeutics, Inc.
- CIK: 0001854151
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: c/o Link Immunotherapeutics, Inc., SEATTLE, WA, 98115
- Phone: (408) 609-0437
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Meininger David | Director | Seattle, WA |
| Daniel O'Connell | Director | Germantown, MD |
| Roger Ulrich | Director | Kenmore, WA |
| Edward van Wezel | Director | Seattle, WA |
| Meininger David | Executive Officer | Seattle, WA |
| Meininger David | Promoter | Seattle, WA |
More